Quantification of HIV-1 RNA Among Men Who Have Sex With Men Using an At-Home Self-Collected Dried Blood Spot Specimen: Feasibility Study

Background: Suboptimal antiretroviral therapy (ART) adherence and disengagement in care present significant public health challenges because of the increased probability of HIV transmission. In the United States, men who have sex with men (MSM) continue to be disproportionately affected by HIV, highlighting a critical need to engage high-risk MSM living with HIV who are not engaged or retained in care. Objective: The aim of the study was to assess the feasibility of at-home blood self-collection and laboratory quantification of HIV-1 RNA viral load (VL) to report laboratory-based VL outcomes and compare self-reported and laboratory-reported VL Methods: Between 2016 and 2017, 766 US HIV-positive MSM enrolled in a Web-based behavioral intervention were invited to participate in an at-home dried blood spot (DBS) collection study using HemaSpot-HF kits (Spot On Sciences, Inc, Austin, TX) for laboratory-quantified VL. Results: Of those invited to participate, 72.3% (554/766) enrolled in the DBS study. Most (79.2%, 439/554) men enrolled reported attempting to collect their blood, 75.5% (418/554) of participants mailed a DBS specimen to the research laboratory, and 60.8% (337/554) had an adequate blood sample for VL testing. Of the 337 specimens tested for VL by the laboratory, 52.5% (177/337) had detectable VL (median: 3508 copies/mL; range: 851-1,202,265 copies/mL). Most men (83.9%, 135/161) who returned a DBS specimen with laboratory-quantified detectable VL self-reported an undetectable VL during their last clinical visit. Conclusions: Home collection of DBS samples from HIV-positive MSM is feasible and has the potential to support clinical VL monitoring. Discrepant laboratory HIV-1 RNA values and self-reported VL indicate a need to address perceived VL status, especially in the era of treatment as prevention. Most participants were willing to use an at-home DBS kit in the future, signaling an opportunity to engage high-risk MSM in long-term HIV care activities

On possibility of measurement of the electron beam energy using absorption of radiation by electrons in a magnetic field

The possibility of the precise measurement of the electron beam energy using absorption of radiation by electrons in a static and homogeneous magnetic field in a range up to a few hundred GeV energies, was considered in [1]. With the purpose of experimental checking of this method in a range of several tens MeV energies, the possibility of measurement of absolute energy of the electron beam energy with relative accuracy up to 10^{-4} is examined in details.Comment: 14 pages, 10 figure

Valuing Governance

Book Summary: As has been abundantly documented in the popular and academic press, the humanities are facing challenging times marked by national debate regarding the importance of the humanities in higher education, program and budget cuts, and an ever-decreasing number of tenure-track jobs. In addition, the humanities face quite literally a quantification of their value as the Academy adopts a more corporate mindset. This volume provides advice to professionals in the humanities on how to forge a useful, compelling, and productive career. The book’s 13 chapters address professional approaches to developing and maintaining an active research agenda, fomenting the ideals of the teacher-scholar model, managing the service demands within and outside the college or university, and navigating institutional politics. The collection offers practical and theoretical approaches to higher education, personal anecdotes, intelligent advice, and interviews with colleagues in the humanities. Specific themes addressed include the transition from graduate student to humanities professional, diverging from prescribed paths, the humanities professor as creative writer, moving from secondary to post-secondary education, humanities in an international, market-based context, and participation in governance structures. [From the publisher] Chapter Summary: This essay focuses on providing insight and practical advice on how committed participation in the governance process offers many positives at any stage of the academic ladder. Drawing upon a practical, theoretical, and anecdotal approach, this article reflects on four areas that are enhanced by participation in governance: 1) visibility; 2) knowledge of the institution and its culture; 3) establishing meaningful friendships campus-wide; and 4) governance as a resource of invaluable advice

Using fNIRS to Identify Transparency- and Reliability-Sensitive Markers of Trust Across Multiple Timescales in Collaborative Human-Human-Agent Triads

Intelligent agents are rapidly evolving from assistants into teammates as they perform increasingly complex tasks. Successful human-agent teams leverage the computational power and sensory capabilities of automated agents while keeping the human operator's expectation consistent with the agent's ability. This helps prevent over-reliance on and under-utilization of the agent to optimize its effectiveness. Research at the intersection of human-computer interaction, social psychology, and neuroergonomics has identified trust as a governing factor of human-agent interactions that can be modulated to maintain an appropriate expectation. To achieve this calibration, trust can be monitored continuously and unobtrusively using neurophysiological sensors. While prior studies have demonstrated the potential of functional near-infrared spectroscopy (fNIRS), a lightweight neuroimaging technology, in the prediction of social, cognitive, and affective states, few have successfully used it to measure complex social constructs like trust in artificial agents. Even fewer studies have examined the dynamics of hybrid teams of more than 1 human or 1 agent. We address this gap by developing a highly collaborative task that requires knowledge sharing within teams of 2 humans and 1 agent. Using brain data obtained with fNIRS sensors, we aim to identify brain regions sensitive to changes in agent behavior on a long- and short-term scale. We manipulated agent reliability and transparency while measuring trust, mental demand, team processes, and affect. Transparency and reliability levels are found to significantly affect trust in the agent, while transparency explanations do not impact mental demand. Reducing agent communication is shown to disrupt interpersonal trust and team cohesion, suggesting similar dynamics as human-human teams. Contrasts of General Linear Model analyses identify dorsal medial prefrontal cortex activation specific to assessing the agent's transparency explanations and characterize increases in mental demand as signaled by dorsal lateral prefrontal cortex and frontopolar activation. Short scale event-level data is analyzed to show that predicting whether an individual will trust the agent, with data from 15 s before their decision, is feasible with fNIRS data. Discussing our results, we identify targets and directions for future neuroergonomics research as a step toward building an intelligent trust-modulation system to optimize human-agent collaborations in real time. &nbsp;</p

Superspace Formulation of Yang- Mills Theory II: Inclusion of Gauge Invariant Operators and Scalars

In a superspace formulation of Yang-Mills theory previously proposed, we show how gauge-invariant operators and scalars can be incorporated keeping intact the (broken) $Osp(3,1|2)$ symmetry of the superspace action. We show in both cases, that the WT identities can be cast in a simple form $\frac{\partial\bar{W}}{\partial\theta}=0$.Comment: Revtex, 19 pages, No figure

Clinical actionability of comprehensive genomic profiling for management of rare or refractory cancers

Background. The frequency with which targeted tumor sequencing results will lead to implemented change in care is unclear. Prospective assessment of the feasibility and limitations of using genomic sequencing is critically important. Methods. A prospective clinical study was conducted on 100 patients with diverse-histology, rare, or poor-prognosis cancers to evaluate the clinical actionability of a Clinical Laboratory Improvement Amendments (CLIA)-certified, comprehensive genomic profiling assay (FoundationOne), using formalin-fixed, paraffin-embedded tumors. The primary objectives were to assess utility, feasibility, and limitations of genomic sequencing for genomically guided therapy or other clinical purpose in the setting of a multidisciplinary molecular tumor board. Results. Of the tumors from the 92 patients with sufficient tissue, 88 (96%) had at least one genomic alteration (average 3.6, range 0–10). Commonly altered pathways included p53 (46%), RAS/RAF/MAPK (rat sarcoma; rapidly accelerated fibrosarcoma; mitogen-activated protein kinase) (45%), receptor tyrosine kinases/ligand (44%), PI3K/AKT/mTOR (phosphatidylinositol-4,5-bisphosphate 3-kinase; protein kinase B; mammalian target of rapamycin) (35%), transcription factors/regulators (31%), and cell cycle regulators (30%). Many low frequency but potentially actionable alterations were identified in diverse histologies. Use of comprehensive profiling led to implementable clinical action in 35% of tumors with genomic alterations, including genomically guided therapy, diagnostic modification, and trigger for germline genetic testing. Conclusion. Use of targeted next-generation sequencing in the setting of an institutional molecular tumor board led to implementable clinical action in more than one third of patients with rare and poor-prognosis cancers. Major barriers to implementation of genomically guided therapy were clinical status of the patient and drug access. Early and serial sequencing in the clinical course and expanded access to genomically guided early-phase clinical trials and targeted agents may increase actionability. Implications for Practice: Identification of key factors that facilitate use of genomic tumor testing results and implementation of genomically guided therapy may lead to enhanced benefit for patients with rare or difficult to treat cancers. Clinical use of a targeted next-generation sequencing assay in the setting of an institutional molecular tumor board led to implementable clinical action in over one third of patients with rare and poor prognosis cancers. The major barriers to implementation of genomically guided therapy were clinical status of the patient and drug access both on trial and off label. Approaches to increase actionability include early and serial sequencing in the clinical course and expanded access to genomically guided early phase clinical trials and targeted agents